We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Reference sheet · Immune · CPC catalog code OBAP-002
Composition figures above are derived arithmetically from the published sequence for the unmodified free peptide. Salt forms (commonly trifluoroacetate or acetate), amidation, and other modifications shift the observed mass — always reconcile against the current lot certificate of analysis.
Volumes for a 1 mg vial of Osteoblast Activating Peptide (mouse, rat) at common working concentrations. Add solvent slowly down the vial wall and swirl — do not vortex or shake.
Reference standards in the Immune class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.
Osteoblast Activating Peptide (mouse, rat) sits within the Immune research class (CPC reference OBAP-002). Immune peptides can serve as MHC-I / MHC-II epitopes, cytokine mimetics, TLR modulators, or antigenic tags. Function is measured by receptor engagement, cytokine release, or downstream T-cell / macrophage activation. Investigators typically incorporate Osteoblast Activating Peptide (mouse, rat) as a reference standard, tool ligand, or substrate in the assay contexts listed above. ELISA, ELISpot, tetramer staining, and flow cytometry are the standard readouts.
Osteoblast Activating Peptide (mouse, rat) (CPC catalog code OBAP-002) is a synthetic immunology research peptide in the immune category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
Published and internal research programs use Osteoblast Activating Peptide (mouse, rat) as a reference standard in immune workflows — for example, mhc / tcr binding and t-cell activation assays and cytokine release and inflammation modeling. Human clinical evidence is not established.
No. Osteoblast Activating Peptide (mouse, rat) is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
In a immune workflow, Osteoblast Activating Peptide (mouse, rat) is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. ELISA, ELISpot, tetramer staining, and flow cytometry are the standard readouts.
Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.